The history of Sildenafil presents a nuanced case for observers in the drug sector. While initially a phenomenal success, producing vast sums, the patent expiration and the subsequent arrival of off-brand versions have significantly affected earnings. This poses questions about the ongoing profitability of similar therapeutic innovations and sug… Read More